https://www.selleckchem.com/products/tween-80.html
Radical (chemo)radiotherapy offers potentially curative treatment for patients with locally advanced laryngeal or hypopharyngeal cancer. We aimed to show that dose-escalated intensity-modulated radiotherapy (DE-IMRT) improved locoregional control. We performed a phase III open-label randomised controlled trial in patients with laryngeal or hypopharyngeal cancer (AJCC III-IVa/b, TNM 7). Patients were randomised (11) to DE-IMRTor standard dose IMRT (ST-IMRT) using a minimisation algorithm, balancing for centre, tumour site, nodal status
Like
Comment
Share
